Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Yefenof

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Experimental Cell Research|August 1, 1977
Differences in the ConA-induced redistribution and agglutination patterns of EBV genome-free and EBV-carrying human lymphoma linesE Yefenof, G Klein, H Ben-Bassat, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1988
The elevated natural killer sensitivity of targets carrying surface-attached C3 fragments require the availability of the iC3b receptor (CR3) on the effectorsO F Ramos, C Kai, E Yefenof, et al.
International Journal of Cancer|April 15, 1979
Moloney lymphoma cells express a polyprotein containing the GAG gene-coded p15 and the Moloney leukemia virus-induced cell surface antigen (MCSA)A Karande, E Yefenof, E M Fenyö, et al.
Immunology Letters|June 15, 1989
Ligands of CR2 do not interfere with C3 fragment fixation or enhanced NK sensitivity of Raji cells treated with human serumE Yefenof, O F Ramos, B Nilsson, et al.
The Journal of Experimental Medicine|December 1, 1977
Immunization of mice with syngeneic Moloney lymphoma cells induces separate antibodies against virion envelope glycoprotein and virus-induced cell surface antigensE M Fenyo, E Yefenof, E Klein, et al.
Complement and Inflammation|January 1, 1991
Activation and fixation of C3 by human B cell lines is enhanced by interferon-gamma and tumor necrosis factor alphaE Yefenof, I Algarra, O F Ramos, et al.
European Journal of Immunology|December 1, 1979
Detection of proteolytic (C 3-cleaving) activity on mouse mastocytoma (P 815) cells and other mouse cell lines by formation of cell contact with C 3-carrying mouse lymphocytesM P Dierich, T Schulz, E Yefenof, et al.
Cellular Immunology|April 1, 1980
C3-activating proteases on human lymphoblastoid cells superinfected with Epstein-Barr VirusT Schulz, M P Dierich, E Yefenof, et al.
International Journal of Cancer|June 15, 1976
Surface markers on human B and T-lymphocytes. IX. Two-color immunofluorescence studies on the association between ebv receptors and complement receptors on the surface of lymphoid cell linesE Yefenof, G Klein, M Jondal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1989
Requirement of leukocytic cell adhesion molecules (CD11a-c/CD18) in the enhanced NK lysis of iC3b-opsonized targetsO F Ramos, M Patarroyo, E Yefenof, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Experimental Cell Research|August 1, 1977
Differences in the ConA-induced redistribution and agglutination patterns of EBV genome-free and EBV-carrying human lymphoma linesE Yefenof, G Klein, H Ben-Bassat, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1988
The elevated natural killer sensitivity of targets carrying surface-attached C3 fragments require the availability of the iC3b receptor (CR3) on the effectorsO F Ramos, C Kai, E Yefenof, et al.
International Journal of Cancer|April 15, 1979
Moloney lymphoma cells express a polyprotein containing the GAG gene-coded p15 and the Moloney leukemia virus-induced cell surface antigen (MCSA)A Karande, E Yefenof, E M Fenyö, et al.
Immunology Letters|June 15, 1989
Ligands of CR2 do not interfere with C3 fragment fixation or enhanced NK sensitivity of Raji cells treated with human serumE Yefenof, O F Ramos, B Nilsson, et al.
The Journal of Experimental Medicine|December 1, 1977
Immunization of mice with syngeneic Moloney lymphoma cells induces separate antibodies against virion envelope glycoprotein and virus-induced cell surface antigensE M Fenyo, E Yefenof, E Klein, et al.
Complement and Inflammation|January 1, 1991
Activation and fixation of C3 by human B cell lines is enhanced by interferon-gamma and tumor necrosis factor alphaE Yefenof, I Algarra, O F Ramos, et al.
European Journal of Immunology|December 1, 1979
Detection of proteolytic (C 3-cleaving) activity on mouse mastocytoma (P 815) cells and other mouse cell lines by formation of cell contact with C 3-carrying mouse lymphocytesM P Dierich, T Schulz, E Yefenof, et al.
Cellular Immunology|April 1, 1980
C3-activating proteases on human lymphoblastoid cells superinfected with Epstein-Barr VirusT Schulz, M P Dierich, E Yefenof, et al.
International Journal of Cancer|June 15, 1976
Surface markers on human B and T-lymphocytes. IX. Two-color immunofluorescence studies on the association between ebv receptors and complement receptors on the surface of lymphoid cell linesE Yefenof, G Klein, M Jondal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1989
Requirement of leukocytic cell adhesion molecules (CD11a-c/CD18) in the enhanced NK lysis of iC3b-opsonized targetsO F Ramos, M Patarroyo, E Yefenof, et al.
Pageof 11